{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:08:33Z","timestamp":1777601313672,"version":"3.51.4"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"suppl_2","license":[{"start":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T00:00:00Z","timestamp":1479081600000},"content-version":"vor","delay-in-days":2015,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"DOI":"10.1093\/nar\/gkr299","type":"journal-article","created":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T07:12:51Z","timestamp":1305097971000},"page":"W492-W498","source":"Crossref","is-referenced-by-count":185,"title":["DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical\u2013protein interactome"],"prefix":"10.1093","volume":"39","author":[{"given":"Heng","family":"Luo","sequence":"first","affiliation":[]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Leming","family":"Shi","sequence":"additional","affiliation":[]},{"given":"Mike","family":"Mikailov","sequence":"additional","affiliation":[]},{"given":"Huang","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Kejian","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[]},{"given":"Lun","family":"Yang","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2011,5,10]]},"reference":[{"key":"key\n\t\t\t\t20170720162416_B1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-6296(91)90001-4","article-title":"Cost of innovation in the pharmaceutical industry","volume":"10","author":"DiMasi","year":"1991","journal-title":"J. Health Econ."},{"key":"key\n\t\t\t\t20170720162416_B2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t20170720162416_B3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1358\/dnp.2009.22.2.1343228","article-title":"The value of drug repositioning in the current pharmaceutical market","volume":"22","author":"Tobinick","year":"2009","journal-title":"Drug News Perspect."},{"key":"key\n\t\t\t\t20170720162416_B4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/13543784.15.11.1295","article-title":"Complementary new approaches enable repositioning of failed drug candidates","volume":"15","author":"Tartaglia","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"key\n\t\t\t\t20170720162416_B5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/pds.2004","article-title":"Quality check of spontaneous adverse drug reaction reporting forms of different countries","volume":"19","author":"Bandekar","year":"2010","journal-title":"Pharmacoepidemiol. Drug Safety"},{"key":"key\n\t\t\t\t20170720162416_B6","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/bioinformatics\/btp369","article-title":"A CitationRank algorithm inheriting Google technology designed to highlight genes responsible for serious adverse drug reaction","volume":"25","author":"Yang","year":"2009","journal-title":"Bioinformatics (Oxford, England)"},{"key":"key\n\t\t\t\t20170720162416_B7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/minf.200900081","article-title":"Structure-based approaches to target fishing and ligand profiling","volume":"29","author":"Rognan","year":"2010","journal-title":"Mol. Inform."},{"key":"key\n\t\t\t\t20170720162416_B8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/wsbm.114","article-title":"Role of systems pharmacology in understanding drug adverse events","volume":"3","author":"Berger","year":"2011","journal-title":"Wiley interdisciplinary reviews. Sys. Biol. Med."},{"key":"key\n\t\t\t\t20170720162416_B9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1371\/journal.pone.0012214","article-title":"Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurements","volume":"5","author":"De Franchi","year":"2010","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170720162416_B10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170720162416_B11","first-page":"239","article-title":"A large-scale computational approach to drug repositioning","volume":"17","author":"Li","year":"2006","journal-title":"Genome Inform."},{"key":"key\n\t\t\t\t20170720162416_B12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1517\/17460440903322234","article-title":"Building a drug-target network and its applications","volume":"4","author":"Lee","year":"2009","journal-title":"Expert Opin. Drug Discovery"},{"key":"key\n\t\t\t\t20170720162416_B13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11095-010-0065-2","article-title":"In-silico approaches to multi-target drug discovery: computer aided multi-target drug design, multi-target virtual screening","volume":"27","author":"Ma","year":"2010","journal-title":"Pharmaceut Res."},{"key":"key\n\t\t\t\t20170720162416_B14","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1021\/bi101540g","article-title":"The chemical basis of pharmacology","volume":"49","author":"Keiser","year":"2010","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170720162416_B15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd2683","article-title":"Mechanisms of drug combinations: interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat. Rev. Drug Discovery"},{"key":"key\n\t\t\t\t20170720162416_B16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.seizure.2009.11.004","article-title":"Cancer informatics for the clinician: an interaction database for chemotherapy regimens and antiepileptic drugs","volume":"19","author":"Yap","year":"2010","journal-title":"Seizure"},{"key":"key\n\t\t\t\t20170720162416_B17","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20170720162416_B18","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170720162416_B19","doi-asserted-by":"crossref","first-page":"14621","DOI":"10.1073\/pnas.1000138107","article-title":"Discovery of drug mode of action and drug repositioning from transcriptional responses","volume":"107","author":"Iorio","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170720162416_B20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/clpt.2009.103","article-title":"Systematic evaluation of drugCDisease relationships to identify leads for novel drug uses","volume":"86","author":"Chiang","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"key\n\t\t\t\t20170720162416_B21","doi-asserted-by":"crossref","first-page":"e1000662","DOI":"10.1371\/journal.pcbi.1000662","article-title":"Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets","volume":"6","author":"Suthram","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20170720162416_B22","doi-asserted-by":"crossref","first-page":"e6536","DOI":"10.1371\/journal.pone.0006536","article-title":"Human disease-drug network based on genomic expression profiles","volume":"4","author":"Hu","year":"2009","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170720162416_B23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1744-8069-6-56","article-title":"Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping","volume":"6","author":"Chang","year":"2010","journal-title":"Mol. Pain"},{"key":"key\n\t\t\t\t20170720162416_B24","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170720162416_B25","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1158\/0008-5472.CAN-07-1601","article-title":"Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation","volume":"67","author":"Tang","year":"2007","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170720162416_B26","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1186\/1471-2105-8-S1-S20","article-title":"p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data","volume":"8","author":"Sbisa","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"key\n\t\t\t\t20170720162416_B27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt1239","article-title":"The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements","volume":"24","author":"Shi","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20170720162416_B28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.1665","article-title":"The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models","volume":"28","author":"Shi","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20170720162416_B29","doi-asserted-by":"crossref","first-page":"e1000441","DOI":"10.1371\/journal.pcbi.1000441","article-title":"Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome","volume":"5","author":"Yang","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20170720162416_B30","doi-asserted-by":"crossref","first-page":"e1002016","DOI":"10.1371\/journal.pcbi.1002016","article-title":"Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome\u2014clozapine-induced agranulocytosis as a case study","volume":"7","author":"Yang","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20170720162416_B31","doi-asserted-by":"crossref","first-page":"W406","DOI":"10.1093\/nar\/gkp312","article-title":"SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome","volume":"37","author":"Yang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170720162416_B32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1011115820450","article-title":"DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases","volume":"15","author":"Ewing","year":"2001","journal-title":"J. Comput.-Aided Mol. Des."},{"key":"key\n\t\t\t\t20170720162416_B33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3565(24)37268-4","article-title":"Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma","volume":"284","author":"Young","year":"1998","journal-title":"J. Phar. Expr. Therap."},{"key":"key\n\t\t\t\t20170720162416_B34","first-page":"3867","article-title":"A potent specific pure antiestrogen with clinical potential","volume":"51","author":"Wakeling","year":"1991","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170720162416_B35","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1200\/JCO.2004.02.112","article-title":"Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial","volume":"22","author":"Howell","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170720162416_B36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1097-2765(00)80047-7","article-title":"Terminal differentiation of human breast cancer through PPAR [gamma]","volume":"1","author":"Mueller","year":"1998","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170720162416_B37","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"New Engl. J. Med."},{"key":"key\n\t\t\t\t20170720162416_B38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-3956(74)90071-5","article-title":"Dose equivalence of the antipsychotic drugs","volume":"11","author":"Davis","year":"1974","journal-title":"J. Psychiat. Res."},{"key":"key\n\t\t\t\t20170720162416_B39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.mehy.2005.01.037","article-title":"The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy","volume":"65","author":"Altschuler","year":"2005","journal-title":"Med. Hypotheses"},{"key":"key\n\t\t\t\t20170720162416_B40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.tpj.6500211","article-title":"Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone","volume":"3","author":"Yamanouchi","year":"2003","journal-title":"Pharmacogenomics J."},{"key":"key\n\t\t\t\t20170720162416_B41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0006-291X(81)91166-9","article-title":"Phospholipid-sensitive calcium-dependent protein kinase: inhibition by antipsychotic drugs","volume":"98","author":"Schatzman","year":"1981","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t20170720162416_B42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1570-0232(03)00393-3","article-title":"Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring","volume":"794","author":"Frahnert","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"key\n\t\t\t\t20170720162416_B43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1192\/bjp.180.6.485","article-title":"Rapid tranquillisation: time for a reappraisal of options for parenteral therapy","volume":"180","author":"McAllister-Williams","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"key\n\t\t\t\t20170720162416_B44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.jcp.0000096247.29231.3a","article-title":"Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?","volume":"23","author":"Rijcken","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"key\n\t\t\t\t20170720162416_B45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.micres.2004.10.002","article-title":"Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine","volume":"160","author":"Rani Basu","year":"2005","journal-title":"Microbiol. Res."},{"key":"key\n\t\t\t\t20170720162416_B46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AAC.01033-06","article-title":"Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei","volume":"51","author":"Chan","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20170720162416_B47","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/nprot.2007.324","article-title":"Integration of biological networks and gene expression data using Cytoscape","volume":"2","author":"Cline","year":"2007","journal-title":"Nat. Protocol."},{"key":"key\n\t\t\t\t20170720162416_B48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/pr.58.2.4","article-title":"Therapeutic targets: progress of their exploration and investigation of their characteristics","volume":"58","author":"Zheng","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"key\n\t\t\t\t20170720162416_B49","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1471-4159.2005.03219.x","article-title":"Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity","volume":"94","author":"Kraus","year":"2005","journal-title":"J. Neurochem."},{"key":"key\n\t\t\t\t20170720162416_B50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1902\/jop.2002.73.6.585","article-title":"The modulation of androgen metabolism by estradiol, minocycline, and indomethacin in a cell culture model","volume":"73","author":"Tilakaratne","year":"2002","journal-title":"J. Periodontol."},{"key":"key\n\t\t\t\t20170720162416_B51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S8756-3282(96)00302-X","article-title":"Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats","volume":"19","author":"Williams","year":"1996","journal-title":"Bone"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/39\/suppl_2\/W492\/18782899\/gkr299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:47:02Z","timestamp":1741182422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article-lookup\/doi\/10.1093\/nar\/gkr299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,10]]},"references-count":51,"journal-issue":{"issue":"suppl_2","published-online":{"date-parts":[[2011,5,10]]},"published-print":{"date-parts":[[2011,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkr299","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,10]]}}}